179 related articles for article (PubMed ID: 10368037)
21. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
Rogers L; Zhang P; Vogelbaum MA; Perry A; Ashby LS; Modi JM; Alleman AM; Galvin J; Brachman D; Jenrette JM; De Groot J; Bovi JA; Werner-Wasik M; Knisely JPS; Mehta MP
J Neurosurg; 2018 Jul; 129(1):35-47. PubMed ID: 28984517
[TBL] [Abstract][Full Text] [Related]
22. Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET.
Combs SE; Welzel T; Habermehl D; Rieken S; Dittmar JO; Kessel K; Jäkel O; Haberkorn U; Debus J
Acta Oncol; 2013 Apr; 52(3):514-20. PubMed ID: 23402336
[TBL] [Abstract][Full Text] [Related]
23. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors.
Milker-Zabel S; Zabel A; Schulz-Ertner D; Schlegel W; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):809-16. PubMed ID: 15708260
[TBL] [Abstract][Full Text] [Related]
24. Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma.
Boskos C; Feuvret L; Noel G; Habrand JL; Pommier P; Alapetite C; Mammar H; Ferrand R; Boisserie G; Mazeron JJ
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):399-406. PubMed ID: 19203844
[TBL] [Abstract][Full Text] [Related]
25. Interstitial radiotherapy of 25 parasellar/clival meningiomas and 19 meningiomas in the elderly. Analysis of short-term tolerance and responses.
Vuorinen V; Heikkonen J; Brander A; Setälä K; Sane T; Randell T; Paetau A; Pohjola J; Mäntylä M; Jääskeläinen J
Acta Neurochir (Wien); 1996; 138(5):495-508. PubMed ID: 8800323
[TBL] [Abstract][Full Text] [Related]
26. Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningioma.
Baumert BG; Villà S; Studer G; Mirimanoff RO; Davis JB; Landau K; Ducrey N; Arruga J; Lambin P; Pica A
Radiother Oncol; 2004 Aug; 72(2):169-74. PubMed ID: 15297135
[TBL] [Abstract][Full Text] [Related]
27. Optimization of stereotactically-guided conformal treatment planning of sellar and parasellar tumors, based on normal brain dose volume histograms.
Perks JR; Jalali R; Cosgrove VP; Adams EJ; Shepherd SF; Warrington AP; Brada M
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):507-13. PubMed ID: 10487578
[TBL] [Abstract][Full Text] [Related]
28. Skull base meningiomas: Long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT).
Combs SE; Adeberg S; Dittmar JO; Welzel T; Rieken S; Habermehl D; Huber PE; Debus J
Radiother Oncol; 2013 Feb; 106(2):186-91. PubMed ID: 22906549
[TBL] [Abstract][Full Text] [Related]
29. Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary results.
Sajja R; Barnett GH; Lee SY; Harnisch G; Stevens GH; Lee J; Suh JH
Technol Cancer Res Treat; 2005 Dec; 4(6):675-82. PubMed ID: 16292888
[TBL] [Abstract][Full Text] [Related]
30. Comparison of intensity-modulated tomotherapy with stereotactically guided conformal radiotherapy for brain tumors.
Khoo VS; Oldham M; Adams EJ; Bedford JL; Webb S; Brada M
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):415-25. PubMed ID: 10487565
[TBL] [Abstract][Full Text] [Related]
31. The visual impact of fractionated stereotactic conformal radiotherapy on seven eyes with optic nerve sheath meningiomas.
Landert M; Baumert BG; Bosch MM; Lütolf UM; Landau K
J Neuroophthalmol; 2005 Jun; 25(2):86-91. PubMed ID: 15937428
[TBL] [Abstract][Full Text] [Related]
32. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.
Hug EB; Devries A; Thornton AF; Munzenride JE; Pardo FS; Hedley-Whyte ET; Bussiere MR; Ojemann R
J Neurooncol; 2000 Jun; 48(2):151-60. PubMed ID: 11083080
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcome after high-precision radiotherapy for skull base meningiomas: Pooled data from three large German centers for radiation oncology.
Combs SE; Farzin M; Boehmer J; Oehlke O; Molls M; Debus J; Grosu AL
Radiother Oncol; 2018 May; 127(2):274-279. PubMed ID: 29598834
[TBL] [Abstract][Full Text] [Related]
34. Highly conformal therapy using proton component in the management of meningiomas. Preliminary experience of the Centre de Protonthérapie d'Orsay.
Noël G; Habrand JL; Mammar H; Haie-Meder C; Pontvert D; Dederke S; Ferrand R; Beaudré A; Gaboriaud G; Boisserie G; Mazeron JJ
Strahlenther Onkol; 2002 Sep; 178(9):480-5. PubMed ID: 12426833
[TBL] [Abstract][Full Text] [Related]
35. Recurrence pattern analysis after [
Zollner B; Ganswindt U; Maihöfer C; Corradini S; Albert NL; Schichor C; Belka C; Niyazi M
Radiat Oncol; 2018 Jun; 13(1):110. PubMed ID: 29898747
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
Adeberg S; Hartmann C; Welzel T; Rieken S; Habermehl D; von Deimling A; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):859-64. PubMed ID: 22137023
[TBL] [Abstract][Full Text] [Related]
37. Cranial nerve outcomes after primary stereotactic radiosurgery for symptomatic skull base meningiomas.
Faramand A; Kano H; Niranjan A; Johnson SA; Hassib M; Park KJ; Arai Y; Flickinger JC; Lunsford LD
J Neurooncol; 2018 Sep; 139(2):341-348. PubMed ID: 29691775
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Clinical Outcomes of Pencil Beam Scanning Proton Therapy for Benign and Non-benign Intracranial Meningiomas.
Murray FR; Snider JW; Bolsi A; Lomax AJ; Walser M; Kliebsch U; Schneider RA; Weber DC
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1190-1198. PubMed ID: 28939227
[TBL] [Abstract][Full Text] [Related]
40. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
